Zhao, Zeda
Qin, Juliang
Qian, Ying
Huang, Chenshen
Liu, Xiaohong
Wang, Ning
Li, Liqin
Chao, Yuqing
Tan, Binghe
Zhang, Na
Qian, Min
Li, Dali
Liu, Mingyao
Du, Bing
Funding for this research was provided by:
National Natural Science Foundation of China (82173099, 81830083, 32270960)
Science and Technology Commission of Shanghai Municipality (23141903300, 23141901800)
National Key R&D Program of China (2018YFA0507001)
Program of Shanghai Academic/Technology Research Leader (23XD1430600)
Article History
Received: 5 September 2023
Accepted: 17 February 2024
First Online: 24 February 2024
Declarations
:
: All animal experiments in this study were evaluated and approved by the Institutional Animal Ethics Committee of East China Normal University. Human lung adenocarcinoma tissues and adjacent normal tissues were collected and handled according to the ethical and safety procedures approved by the Clinical Ethics Committee of the Huzhou Central Hospital, Affiliated Hospital of Zhejiang University and the lung cancer tissue array (HLugA180Su08) was purchased from Shanghai Outdo Biotech.
: Not applicable.
: The authors declare that they have no competing interests.